Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
blood cancer
Pharma
Daiichi Sankyo bags an industry first for blood cancer drug
The go-ahead makes Ezharmia the first dual EZH1/2 inhibitor to receive regulatory approval anywhere in the world.
Angus Liu
Sep 26, 2022 11:02am
FDA adcomm votes down Secura's PI3K drug in CLL
Sep 23, 2022 3:06pm
FDA threatens to clamp down on another PI3K blood cancer drug
Sep 22, 2022 3:17pm
AbbVie cancer survey reveals CLL emotional roller coaster
Aug 24, 2022 7:35am
FDA puts the microscope on 2 more cancer approvals
Jul 22, 2022 11:12am
There are too many blood cancer cell therapies in development
Jul 20, 2022 9:00am
